GlassScriptPhysician profile
Deepa Cherla Patel
NPI 1265876684
$5,273.36
in general payments reported to CMS, 2019-2025
17 companies · $1,580 in 2025
The $1,580 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $95.71 · 2023: $2,145 · 2024: $1,453 · 2025: $1,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,735 · Education: $1,662 · Long Term Medical Supply Or Device Loan: $781.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,734.57 |
| Education | $1,661.69 |
| Long Term Medical Supply Or Device Loan | $781.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,504.18 | 2023-2024 | Da Vinci Surgical System, Davinci Xi |
| Medtronic, INC. | $843.49 | 2022-2025 | Sonicision, Signia |
| Integra Lifesciences Corporation | $809.35 | 2025 | Micromatrix, Cytal, Integra |
| Mimedx Group, INC. | $624.95 | 2024-2025 | |
| Kerecis Limited | $505.29 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Baxter Healthcare | $220.73 | 2023-2024 | Peri-Strips Dry |
| Aroa Biosurgery Incorporated | $181.55 | 2024 | |
| W. L. Gore & Associates, INC. | $161.69 | 2023 | Seamguard Staple Line Reinforcement |
| Astrazeneca Pharmaceuticals LP | $136.48 | 2022-2025 | Enhertu |
| Tela Bio, INC. | $72.22 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Innovation Technologies INC | $58.26 | 2024 | Irrisept |
| Davol INC. | $39.81 | 2025 | Phasix Mesh |
| Elucent Medical | $34.67 | 2023-2025 | |
| Lemaitre Vascular, INC. | $25.95 | 2025 | Artegraft Vascular Graft |
| Pacira Pharmaceuticals Incorporated | $20.92 | 2025 | Exparel |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $18.05 | 2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $15.77 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.